These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25003616)

  • 1. Nephrotic syndrome: Rituximab is safe and effective in FRNS and SDNS--but where to go from here?
    Razzak M
    Nat Rev Nephrol; 2014 Aug; 10(8):421. PubMed ID: 25003616
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
    Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for childhood-onset nephrotic syndrome.
    Hodson EM; Craig JC
    Lancet; 2014 Oct; 384(9950):1242-3. PubMed ID: 24965824
    [No Abstract]   [Full Text] [Related]  

  • 4. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
    Ito S; Kamei K; Ogura M; Udagawa T; Fujinaga S; Saito M; Sako M; Iijima K
    Pediatr Nephrol; 2013 Feb; 28(2):257-64. PubMed ID: 23052656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for patients with nephrotic syndrome.
    Arnold DF; Misbah SA
    Lancet; 2015 Jan; 385(9964):226. PubMed ID: 25706702
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab for patients with nephrotic syndrome.
    Keijzer-Veen MG; Hebert D; Parekh RS;
    Lancet; 2015 Jan; 385(9964):225. PubMed ID: 25706701
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab for patients with nephrotic syndrome.
    Shin JI; Kronbichler A
    Lancet; 2015 Jan; 385(9964):225-6. PubMed ID: 25706700
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab for patients with nephrotic syndrome--authors' reply.
    Iijima K; Sako M; Nozu K; Nakamura H; Ito S
    Lancet; 2015 Jan; 385(9964):226-7. PubMed ID: 25706703
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrotic syndrome: Rituximab in childhood steroid-dependent nephrotic syndrome.
    Boyer O; Niaudet P
    Nat Rev Nephrol; 2013 Oct; 9(10):562-3. PubMed ID: 23938594
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab for childhood refractory nephrotic syndrome.
    Iijima K
    Pediatr Int; 2011 Oct; 53(5):617-621. PubMed ID: 21771179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.
    DaSilva I; Huerta A; Quintana L; Redondo B; Iglesias E; Draibe J; Praga M; Ballarín J; Díaz-Encarnación M;
    BioDrugs; 2017 Jun; 31(3):239-249. PubMed ID: 28534103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
    Ravani P; Ponticelli A; Siciliano C; Fornoni A; Magnasco A; Sica F; Bodria M; Caridi G; Wei C; Belingheri M; Ghio L; Merscher-Gomez S; Edefonti A; Pasini A; Montini G; Murtas C; Wang X; Muruve D; Vaglio A; Martorana D; Pani A; Scolari F; Reiser J; Ghiggeri GM
    Kidney Int; 2013 Nov; 84(5):1025-33. PubMed ID: 23739238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.
    Iijima K; Sako M; Kamei K; Nozu K
    Pediatr Nephrol; 2018 Sep; 33(9):1449-1455. PubMed ID: 28717938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
    BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab].
    Kamei K; Okada M; Miyazono A; Sato M; Fujimaru T; Ogura M; Ito S
    Nihon Jinzo Gakkai Shi; 2013; 55(5):947-55. PubMed ID: 23980480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai.
    Sun L; Xu H; Shen Q; Cao Q; Rao J; Liu HM; Fang XY; Zhou LJ
    World J Pediatr; 2014 Feb; 10(1):59-63. PubMed ID: 24464665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is rituximab effective in childhood nephrotic syndrome? Yes and no.
    Kemper MJ; Lehnhardt A; Zawischa A; Oh J
    Pediatr Nephrol; 2014 Aug; 29(8):1305-11. PubMed ID: 23820888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we consider MMF therapy after rituximab for nephrotic syndrome?
    Filler G; Huang SH; Sharma AP
    Pediatr Nephrol; 2011 Oct; 26(10):1759-62. PubMed ID: 21533869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome.
    Sinha A; Bagga A; Gulati A; Hari P
    Pediatr Nephrol; 2012 Feb; 27(2):235-41. PubMed ID: 21922213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial).
    Nagano C; Sako M; Kamei K; Ishikura K; Nakamura H; Nakanishi K; Omori T; Nozu K; Iijima K
    BMC Nephrol; 2019 Aug; 20(1):293. PubMed ID: 31375087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.